Skip to content
HowShorted

Replimune Group, Inc. short interest in 2020

In 2020, Replimune Group, Inc.'s disclosed short interest ran from 1.81% of shares outstanding on 15 Jan 2020 to 5.86% on 31 Dec 2020, a change of +4.05 percentage points. The year's high was 5.86% on 31 Dec 2020 and its low 1.14% on 29 May 2020, averaging 2.15% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.22 days on 30 Apr 2020. Full history: Replimune Group, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Replimune Group, Inc. in 2020

2020 in figures

Start of year
1.81% (15 Jan 2020)
End of year
5.86% (31 Dec 2020)
Change
+4.05 pp
High
5.86% (31 Dec 2020)
Low
1.14% (29 May 2020)
Average
2.15%
Highest days to cover
15.22 (30 Apr 2020)
SEC filings marked
8

Every report in 2020

Replimune Group, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20201.81%5.20results (8-K)
31 Jan 20202.16%4.89
14 Feb 20201.99%9.7210-Q filed
28 Feb 20201.87%8.41
13 Mar 20201.93%8.31
31 Mar 20202.01%8.11
15 Apr 20202.23%11.40
30 Apr 20202.16%15.22
15 May 20201.17%3.14
29 May 20201.14%6.29
15 Jun 20202.40%2.5010-K filed, results (8-K)
30 Jun 20201.51%1.79
15 Jul 20201.27%2.03
31 Jul 20201.59%4.46
14 Aug 20201.69%6.0410-Q filed, results (8-K)
31 Aug 20201.54%7.16
15 Sep 20201.87%3.39
30 Sep 20202.54%3.24
15 Oct 20202.14%1.00
30 Oct 20202.79%1.31
13 Nov 20202.72%2.7010-Q filed, results (8-K)
30 Nov 20202.39%3.52
15 Dec 20202.84%3.64
31 Dec 20205.86%3.50

See also: Replimune Group, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.